Review Article
Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals
Table 4
Clinical status of antifungal drugs used in onychomycosis.
| Therapeutic agent | Clinical status | Reference |
| Amorolfine/RV4104A/Ciclopiroxolamine | Unknown | [25] | Econail™ (econazole) | Phase II (completed) | [26] | Phytonail/Loceryl | Unknown | [25] | Terbinafine hydrochloride/amorolfine | Completed | [25] | Terbinafine hydrochloride | Completed | [25] | Ciclopirox | Completed | [25] | Amorolfine/terbinafine | Completed | [25] | MycoVa™ | Phase III (completed) | [26] | Er:YAG laser (device) with amorolfine | Unknown | [25] | Luliconazole (solution) | Phase IIb/III (ongoing) | [25] | Efinaconazole (10% topical solution) | Phase III (completed) | [27] | TDT067 (liquid spray) | Phase III (ongoing) | [26] | P-3058 | Phase II (ongoing) | [26] | Isavuconazole | Phase III (completed) | [28] | Tavaborole | Phase III (completed) | [29] | Albaconazole | Phase II (completed) | [30] | Posaconazole | Phase II (completed) | [30] | VT-1161 | Phase II (ongoing) | [31] |
|
|